Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0W0AF
|
||||
Former ID |
DNC004739
|
||||
Drug Name |
Des-AA1,2,5-[D-Trp8,(NalphaMe)IAmp9]SRIF
|
||||
Indication | Discovery agent | Investigative | [527384] | ||
Structure |
Download2D MOL |
||||
Formula |
C75H98N14O15S2
|
||||
Canonical SMILES |
CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(<br />C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2C)<br />CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)N)C(<br />=O)O)CO)C(C)O)CC7=CC=CC=C7)C(C)O
|
||||
InChI |
1S/C75H98N14O15S2/c1-43(2)78-38-50-30-28-49(29-31-50)36-62-71(99)88-64(45(4)92)72(100)83-58(35-48-23-13-8-14-24-48)69(97)87-63(44(3)91)73(101)85-60(40-90)70(98)86-61(75(103)104)42-106-105-41-53(77)65(93)80-55(27-17-18-32-76)66(94)81-56(33-46-19-9-6-10-20-46)67(95)82-57(34-47-21-11-7-12-22-47)68(96)84-59(74(102)89(62)5)37-51-39-79-54-26-16-15-25-52(51)54/h6-16,19-26,28-31,39,43-45,53,55-64,78-79,90-92H,17-18,27,32-38,40-42,76-77H2,1-5H3,(H,80,93)(H,81,94)(H,82,95)(H,83,100)(H,84,96)(H,85,101)(H,86,98)(H,87,97)(H,88,99)(H,103,104)/t44-,45-,53-,55-,56-,57+,58+,59+,60+,61+,62+,63-,64-/m1/s1
|
||||
InChIKey |
SRQXVUQUEBDWHI-YNBIXHCXSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Somatostatin receptor 1 | Target Info | Inhibitor | [527384] | |
Somatostatin receptor type 4 | Target Info | Inhibitor | [527384] | ||
Somatostatin receptor type 3 | Target Info | Inhibitor | [527384] | ||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
PathWhiz Pathway | Gastric Acid Production | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.